Vitamin D Lack Linked to IBD, Liver Disease
Posted on: Wednesday, 8 October 2008, 00:00 CDT
Vitamin D deficiency is common in patients with inflammatory bowel disease and chronic liver disease, U.S. researchers say.
Researchers at the Medical College of Wisconsin investigated whether Vitamin D deficiency in patients with inflammatory bowel disease is associated with a lower quality of life or higher disease activity independent of other known risk factors and medication use.
This study conducted by Dr. Alex Ulitsky and his colleagues analyzed Vitamin D levels of 504 inflammatory bowel disease patients and recorded the patients' lowest Vitamin D measurements.
Ulitsky and his team found almost 50 percent of the patients were Vitamin D deficient at some point, with 11 percent being severely deficient.
Researchers from the University of Tennessee in Memphis measured the Vitamin D levels of 118 chronic liver disease patients. Researchers found 92.4 percent of chronic liver patients had some degree of Vitamin D deficiency and at least one-third were severely deficient. Severe Vitamin D deficiency was more common among cirrhotics.
"Since deficiency is common among these patients, Vitamin D replacement may hopefully prevent osteoporosis and other bone complications related to end stage liver disease," said lead researcher Dr. Satheesh P. Nair.
Source: United Press International
Related Articles
- Patient Data Analysis Report Finds More Than 75 Percent of Chronically Ill Patients Unable to Obtain Needed Healthcare Have Some Form of Insurance
- Study Suggests Survival Benefit From Radioactive Microsphere Therapy in Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy
- New Scientists Boost Disease-Based Research at Boston Biomedical Research Institute
- FoldRx Announces Study Defining Role of Key Protein and Biological Pathway Implicated in Parkinson's Disease; Collaborators' Research in Science Points Way to New Treatment Approaches and Validates Company's Discovery Engine
- Covalent Group, Inc. Announces $2.1 Million Contract To Conduct Patient Disease Registry In Hospitalized Subjects With Hyponatremia
- Covalent Group, Inc. And Sudler & Hennessey Announce Strategic Partnership to Design and Conduct Global Patient Disease Registries
- Medivir: Advances in Chronic Obstructive Pulmonary Disease (COPD) Research Program
- Impaired Memory and General Intelligence Related to Severity and Duration of Patients' Disease in Type A Posttraumatic Stress Disorder
- Vitamin E 'Prevents Disease'
User Comments (0)
RSS Feeds